Search results for " therapeutic" in Articles / App Notes
Article
Chromatography innovations for the diverse antibody pipeline
To support development of new therapeutic possibilities, manufacturing and process development technologies must also evolve. For antibody variants, platform purification protocols for conve…
Article
Late stage failures of monoclonal antibodies
Despite the significant developments that have happened in clinical trial design and the considerable experience that the biopharma industry has gained in the past three decades, therapeutic…
Article
Analytical Considerations for Successful Upstream Process Development with Spivey and Lane
Cytiva provides bioprocessing products and services to the biopharmaceutical industry for the development and manufacturer of therapeutics and vaccines. The company uses its scientific knowledge and t…
Article
Oligonucleotide Development and Manufacturing Workflow
Click here to view >>
Learn more on key considerations when setting up an oligonucleotide workflow with this infographic.
Article
Track-and-Trace Progress Benefits Supply-Chain Security Efforts
Since the COVID-19 pandemic struck, there has been little news of serialization breakthroughs, as manufacturers and their supply partners have focused on getting new therapeutics and vaccines to patie…
Article
Antibody Production Workflow
Explore the workflow here >>
Antibody-based therapies have evolved beyond monoclonal antibodies (mAbs) to include bispecific antibodies, antibody fragments, antibody-drug conjugates (ADCs), and m…
Article
Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
The rise of therapeutic monoclonal antibodies (mAbs) in the 1980s drove the requirement to adapt Chinese hamster ovary (CHO) cells to suspension in order to allow the use of stirred tank bioreactor fo…
Article
Setting Up Bioprocessing Systems for Digital Transformation
Meanwhile, for therapeutic applications, processes need to be run to current good manufacturing practice (CGMP) standards, and tend to be designed to not have many decision points, to aid with complia…
Article
Common Challenges in Cross-Functional Process Development
…opment and quality that encompasses early process development to commercial operations for all major therapeutic classes.
Topic covered include:
1:28 – Common stumbling blocks in develo…
Article
Future Downstream Process Development Solutions for Advanced Therapies
Related Content
Q&As with Industry Leaders
mRNA manufacturing strategies
Manufacturing of viral vectors
Purification of plasmids
Oligonucleotide therapeutics